Cargando…
Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy
Rezum therapy is in emerging minimally invasive treatment for BPH. Complications of Rezum are underreported in the literature. We report a case of a 61-year-old male patient who presented to ED two months after Rezum with hematuria and clot retention. US showed prostate size of 315 g with cystic cha...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188957/ https://www.ncbi.nlm.nih.gov/pubmed/35707222 http://dx.doi.org/10.1016/j.eucr.2022.102125 |